首页 > 市场调查报告书 > 食物/饮料

保健食品机能性食品

市场调查报告书

商品编码

1587919

核黄素市场：依形式、依来源、依应用、按地区

Riboflavin Market, By Form, By Source, By Application, By Geography

出版日期: 2024年10月23日 | 出版商:

Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3个工作天内

价格

简介目录

核黄素市场预计到2024年将达到4.615亿美元，到2031年将达到7.26亿美元，2024年至2031年的复合年增长率为6.7%。

报告范围		报告详情
基准年	2023年	2024年市场规模	4.615 亿美元
实际资料	2019-2023	预测期	2024-2031
预测期间（2024-2031）复合年增长率：	6.70%	2031 年金额预测	7.26 亿美元

图：2024 年按地区分類的核黄素市场占有率(%)

核黄素又称维生素B2，是人体生长发育所需的必需营养素。它作为黄素单核苷酸和黄素腺嘌呤二核苷酸的前体，在各种代谢过程中发挥重要作用。核黄素是一种水溶性维生素，必须从饮食中摄取。核黄素天然存在于多种食品中，包括牛奶、鸡蛋、肉类、绿叶类、蘑菇和豆类。缺乏核黄素会导致健康问题，例如嘴角干裂、口腔内发炎、喉咙痛、皮肤搔痒和脂漏性皮肤炎。由于健康意识的提高和膳食食品需求的增加，全球核黄素在不久的将来可能会出现增长。

市场动态

全球核黄素市场的成长是由消费者对营养食品偏好的增加、健康意识的提高、核黄素缺乏病例的增加以及食品和饮料行业的扩张等因素所推动的。然而，从食品或合成生产中天然提取核黄素的高成本可能会阻碍市场成长。核黄素作为药品、化妆品和饲料添加剂的新用途可能会开闢新的市场扩张途径。然而，由于许多日常食品都含有核黄素，市场面临一定的限制因素。严格的食品补充剂监管标准可能会阻碍市场成长。核黄素很难透过非肉类饮食获得，因此越来越多地采用素食和素食饮食可能代表着一个增长机会。导致配方改进的产品创新带来了另一个成长前景。

本研究的主要特点

该报告详细分析了全球核黄素市场，并提供了以 2023 年为基准年的预测期（2024-2031）的市场规模（百万美元）和年复合成长率（CAGR%）。

它还阐明了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球核黄素市场中主要企业的概况。

本研究涵盖的主要企业有BASF股份公司、皇家帝斯曼公司、上海创诺药业集团有限公司、信发药业股份有限公司、湖北广济药局股份有限公司、NB集团有限公司、Hegno、联想工业有限公司、河北圣雪大成药业有限公司、Duchefa Biochemie、Harman Finichem有限公司等

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

核黄素全球市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球核黄素市场的各种策略矩阵来促进他们的决策。

热图分析
市场占有率分析（3x3矩阵）
公司简介
- BASF SE
- Koninklijke DSM NV
- Shanghai Acebright Pharmaceuticals Group Co. Ltd.
- Xinfa Pharmaceutical Co. Ltd
- Hubei Guangji Pharmaceutical Co. Ltd
- NB Group Co. Ltd
- Hegno
- Legend Industries
- Hebei Shengxue dacheng Pharmaceutical Co. Ltd
- Duchefa Biochemie
- Harman Finichem Ltd

第10章分析师建议

命运之轮
分析师观点
Coherent Opportunity Map

第11章章节

参考
调查方法

简介目录

Product Code: CMI5140

Riboflavin market is estimated to be valued at USD 461.5 Mn in 2024 and is expected to reach USD 726.0 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 461.5 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.70%	2031 Value Projection:	US$ 726.0 Mn

Figure. Riboflavin Market Share (%), By Region 2024

Riboflavin, also known as vitamin B2, is an essential nutrient required by the human body for growth and development. It plays a vital role in various metabolic processes through its involvement as a precursor for flavin mononucleotide and flavin adenine dinucleotide. As a water-soluble vitamin, riboflavin needs to be supplemented through diet. It is naturally present in a variety of foods including milk, eggs, meat, leafy green vegetables, mushrooms, and legumes. Deficiency of riboflavin can lead to health issues like cracks at the corners of the mouth, inflammation of the mouth, sore throat, itchy skin, and seborrheic dermatitis. Due to growing health awareness and increasing demand for nutritional supplements, global riboflavin can witness growth in the near future.

Market Dynamics-

Global riboflavin market growth is driven by factors such as increasing consumer preference for nutritional supplements, growing health consciousness, rising cases of riboflavin deficiencies, and expanding food & beverage industry. However, high costs associated with natural extraction of riboflavin from foods and synthetic production can hamper the market growth. Novel applications of riboflavin as an additive in pharmaceuticals, cosmetics and animal feed can present new avenues for market expansion. However, the market faces certain restraints due to presence of riboflavin in many routine foods. Strict regulatory norms governing dietary supplements can hamper the market growth. Increasing adoption of vegan and vegetarian diets as riboflavin intake can be challenging through a non-meat diet can offer growth opportunities. Product innovation leading to enhanced formulations presents another favorable growth prospect.

Key Features of the Study-

This report provides in-depth analysis of the global riboflavin market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd., Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, Hebei Shengxue dacheng Pharmaceutical Co. Ltd, Duchefa Biochemie, and Harman Finichem Ltd

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Market Segmentation

Form Insights (Revenue, USD, 2019 - 2031)
- Powder
- Liquid
Source Insights (Revenue, USD, 2019 - 2031)
- Plant
- Animal
Application Insights (Revenue, USD, 2019 - 2031)
- Food and Beverages
- Dietary Supplements
- Pharmaceutical
- Animal Feed
- Personal Care
- Others
Regional Insights (Revenue, USD, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- BASF SE
- Koninklijke DSM NV
- Shanghai Acebright Pharmaceuticals Group Co. Ltd.
- Xinfa Pharmaceutical Co. Ltd
- Hubei Guangji Pharmaceutical Co. Ltd
- NB Group Co. Ltd
- Hegno
- Legend Industries
- Hebei Shengxue dacheng Pharmaceutical Co. Ltd
- Duchefa Biochemie
- Harman Finichem Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Form
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Riboflavin Market - Impact of Coronavirus (COVID-19) Pandemic

Overview
Factors Affecting the Global Riboflavin Market - COVID-19
Impact Analysis

5. Global Riboflavin Market, By Form, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Powder
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Liquid
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Segment Trends

6. Global Riboflavin Market, By Source, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Plant
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Animal
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends

7. Global Riboflavin Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Food and Beverages
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Dietary Supplements
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Pharmaceutical
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Animal Feed
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Personal Care
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
Others
- Market Share Analysis, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends

8. Global Riboflavin Market, By Region, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024, 2027, and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
North America
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
- Y-o-Y Growth Analysis, For Country, 2020 - 2031
- Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019- 2031, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- BASF SE
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Koninklijke DSM NV
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Shanghai Acebright Pharmaceuticals Group Co. Ltd.
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Xinfa Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hubei Guangji Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- NB Group Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hegno
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Legend Industries
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Hebei Shengxue dacheng Pharmaceutical Co. Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Duchefa Biochemie
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates
- Harman Finichem Ltd
  - Company Overview
  - Chair Type Portfolio
  - Recent Developments/Updates

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

核黄素市场：依形式、依来源、依应用、按地区

Riboflavin Market, By Form, By Source, By Application, By Geography

目录

第一章研究目的与前提

第二章市场展望

第三章市场动态、法规与趋势分析

第四章全球核黄素市场－冠状病毒 (COVID-19) 大流行的影响

第五章全球核黄素市场，依形式划分，2019-2031（百万美元）

第六章 2019-2031 年全球核黄素市场（依来源）（百万美元）

第七章全球核黄素市场，依应用分类，2019-2031（百万美元）

第八章全球核黄素市场，按地区，2019-2031（百万美元）

第9章竞争格局